dalteparin has been researched along with polidocanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Exner, T; Joseph, JE; Low, J; Ma, DD; Parsi, K | 1 |
Altmeyer, P; Doerler, M; Reich-Schupke, S; Stücker, M | 1 |
2 other study(ies) available for dalteparin and polidocanol
Article | Year |
---|---|
In vitro effects of detergent sclerosants on antithrombotic mechanisms.
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Detergents; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa; Heparin; Humans; Partial Thromboplastin Time; Polidocanol; Polyethylene Glycols; Protein C; Protein S; Prothrombin; Prothrombin Time; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Thrombosis | 2009 |
Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome.
Topics: Anticoagulants; Combined Modality Therapy; Drug Administration Schedule; Enoxaparin; Humans; Polidocanol; Polyethylene Glycols; Postthrombotic Syndrome; Recurrence; Retrospective Studies; Risk Factors; Sclerotherapy; Thromboembolism; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Duplex; Varicose Veins | 2013 |